Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy

References

• Borch‐Johnsen K., Norgaard K., Hommel E., Mathiesen E. R., Jensen J. S., Deckert T., et al. Is diabetic nephropathy an inherited complication?. Kidney Int 1992; 41: 719–22
   PubMed Web of Science ®Google Scholar
• Doria A., Warram J. H., Krolewski A. S. Genetic susceptibility to nephropathy in insulin‐dependent diabetes: from epidemiology to molecular genetics. Diabetes Metab Rev 1995; 11: 287–314
   PubMedGoogle Scholar
• Quinn M., Angelico M. C., Warram J. H., Krolewski A. S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940–5
   PubMed Web of Science ®Google Scholar
• Scott L. J., Warram J. H., Hanna L. S., Laffel L. M., Ryan L., Krolewski A. S. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 2001; 50: 2842–9
   PubMedGoogle Scholar
• Christiansen J. S. Cigarette smoking and prevalence of microangiopathy in juvenile‐onset insulin‐dependent diabetes mellitus. Diabetes Care 1978; 1: 146–9
   PubMedGoogle Scholar
• Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin‐dependent patients. N Engl J Med 1984; 311: 89–93
   PubMed Web of Science ®Google Scholar
• Rudberg S., Osterby R., Dahlquist G., Nyberg G., Persson B. Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM. Diabetes Care 1997; 20: 265–71
   Google Scholar
• Zatz R., de Nucci G. Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 1991; 261((Pt 2))F360–3
   Google Scholar
• Krolewski A. S., Poznik G. D., Placha G., Canani L., Dunn J., Walker W., et al. A genome‐wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 2006; 69: 129–36
   PubMed Web of Science ®Google Scholar
• Sugimoto H., Shikata K., Matsuda M., Kushiro M., Hayashi Y., Hiragushi K., et al. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 1998; 41: 1426–34
   PubMed Web of Science ®Google Scholar
• Wang X. L., Mahaney M. C., Sim A. S., Wang J., Blangero J., Almasy L., et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997; 17: 3147–53
   PubMed Web of Science ®Google Scholar
• Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998; 245: 190–3
   PubMed Web of Science ®Google Scholar
• Neugebauer S., Baba T., Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 2000; 49: 500–3
   PubMed Web of Science ®Google Scholar
• Zanchi A., Moczulski D. K., Hanna L. S., Wantman M., Warram J. H., Krolewski A. S. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000; 57: 405–13
   PubMed Web of Science ®Google Scholar
• Shimizu T., Onuma T., Kawamori R., Makita Y., Tomino Y. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 2002; 58: 179–85
   PubMed Web of Science ®Google Scholar
• Rippin J. D., Patel A., Belyaev N. D., Gill G. V., Barnett A. H., Bain S. C. Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 2003; 46: 426–8
   PubMed Web of Science ®Google Scholar
• Miyamoto Y., Saito Y., Kajiyama N., Yoshimura M., Shimasaki Y., Nakayama M., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3–8
   PubMed Web of Science ®Google Scholar
• Shimasaki Y., Yasue H., Yoshimura M., Nakayama M., Kugiyama K., Ogawa H., et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506–10
   PubMed Web of Science ®Google Scholar
• Noiri E., Satoh H., Taguchi J., Brodsky S. V., Nakao A., Ogawa Y., et al. Association of eNOS Glu298Asp polymorphism with end‐stage renal disease. Hypertension 2002; 40: 535–40
   PubMed Web of Science ®Google Scholar
• Kugiyama K., Yasue H., Ohgushi M., Motoyama T., Kawano H., Inobe Y., et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996; 28: 1161–7
   PubMed Web of Science ®Google Scholar
• McVeigh G. E., Lemay L., Morgan D., Cohn J. N. Effects of long‐term cigarette smoking on endothelium‐dependent responses in humans. Am J Cardiol 1996; 78: 668–72
   PubMed Web of Science ®Google Scholar
• Barua R. S., Ambrose J. A., Eales‐Reynolds L. J., DeVoe M. C., Zervas J. G., Saha D. C. Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation. J Am Coll Cardiol 2002; 39: 1758–63
   PubMed Web of Science ®Google Scholar
• Wang X. L., Sim A. S., Badenhop R. F., McCredie R. M., Wilcken D. E. A smoking‐dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41–5
   PubMed Web of Science ®Google Scholar
• Barrett J. C., Fry B., Maller J., Daly M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–5
   PubMed Web of Science ®Google Scholar
• Purcell S., Cherny S. S., Sham P. C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149–50
   PubMed Web of Science ®Google Scholar
• Rothman K. J. Modern Epidemiology. Little, Brown and Company, Boston 1986, 1st ed.
   Google Scholar
• Schultz C. J., Konopelska‐Bahu T., Dalton R. N., Carroll T. A., Stratton I., Gale E. A., et al. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 1999; 22: 495–502
   PubMed Web of Science ®Google Scholar
• Svensson M., Eriksson J. W., Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood‐onset type 1 diabetes: a population‐based study in northern Sweden. Diabetes Care 2004; 27: 955–62
   PubMed Web of Science ®Google Scholar
• Degen B., Schmidt S., Ritz E. A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. Nephrol Dial Transplant 2001; 16: 185
   PubMed Web of Science ®Google Scholar
• Colhoun H. M., McKeigue P. M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865–72
   PubMed Web of Science ®Google Scholar
• Rudberg S., Persson B., Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy—an 8‐year prospective study. Kidney Int 1992; 41: 822–8
   PubMed Web of Science ®Google Scholar
• Brenner B. M. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983; 23: 647–55
   PubMed Web of Science ®Google Scholar
• Chu S., Bohlen H. G. High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism. Am J Physiol Renal Physiol 2004; 287: F384–92
   PubMed Web of Science ®Google Scholar
• Mollsten A., Svensson M., Kockum I., Rudberg S., Brismar K., Dahlquist G. Increased risk for diabetic nephropathy in smoking patients carrying a polymorphism in the endothelial cell nitric oxide synthase gene. Diabetologia Supplement 2004; 47(Suppl 1): A48
   Google Scholar
• Pettersson‐Fernholm K., Karvonen M. K., Kallio J., Forsblom C. M., Koulu M., Pesonen U., et al. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients. Diabetes Care 2004; 27: 503–9
   Google Scholar